French Pharma Stock News

Renault SA recently reported its 2025 results, revealing worldwide sales of 2,336,807 vehicles, a 3.2% increase in a market that grew 1.6%, while Renault Trucks Europe appointed Carlos Rodrigues as senior vice president from February 1, 2026, to succeed Christophe Deshayes and oversee European operations. The combination of outpacing overall market growth across all three complementary brands and refreshing leadership at Renault Trucks Europe highlights how Renault is trying to strengthen...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...

When close to half the companies in the Media industry in France have price-to-sales ratios (or "P/S") below 0.5x, you...

Adocia SA ( EPA:ADOC ) is possibly approaching a major achievement in its business, so we would like to shine some...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider MGI...

Key Insights The considerable ownership by individual investors in ATEME indicates that they collectively have a...

Aubay Société Anonyme's (EPA:AUB) stock is up by a considerable 23% over the past three months. Given the company's...

Key Insights Significant insider control over Séché Environnement implies vested interests in company growth Joel Seche...

Key Insights The considerable ownership by private companies in Compagnie des Alpes indicates that they collectively...

LVMH Moët Hennessy - Louis Vuitton, Société Européenne ( EPA:MC ) will pay a dividend of €7.50 on the 30th of April...

TF1's (EPA:TFI) stock up by 6.2% over the past three months. We wonder if and what role the company's financials play...

If you are wondering whether Sanofi shares offer good value right now, the key is to look closely at what the current price is actually baking in about the company. The stock closed at €80.45 recently, with returns of 0.7% over the past week, a 2.3% decline over the last month, and a 19.6% decline over the last year, while the 3 year and 5 year returns sit at 6.9% and 21.3% respectively. Recent attention on Sanofi has been shaped by broader sector news and company specific updates around its...

Arkema has been awarded the EcoVadis Gold Medal for sustainable development leadership. This recognition places the company among the higher ranked organizations globally for sustainability practices. The award highlights Arkema's progress on environmental, social, and governance priorities that matter to many investors. For investors tracking Arkema (ENXTPA:AKE), this sustainability recognition comes as the shares trade around €51.4. The stock has seen a 27.8% decline over the past year...

Christian Dior SE has reported its full-year 2025 results, with sales of €80.81 billion and net income of €4.53 billion, both lower than the prior year. The drop in both basic and diluted earnings per share from continuing operations highlights pressure on profitability across Christian Dior’s core activities. We will now examine how this earnings decline, particularly the reduction in sales, may shape Christian Dior’s broader investment narrative. The end of cancer? These 29 emerging AI...

Eiffage (ENXTPA:FGR) is back in focus after its SEH Engineering unit, together with BEMO Tunnelling and Metrostav DIZ, secured a €183 million contract to build the new Levensau Bridge on Germany's Kiel Canal. See our latest analysis for Eiffage. The latest contract win in Germany comes as Eiffage’s share price sits at €126.0, with recent momentum reflected in a 16.77% 90 day share price return and a 51.73% 1 year total shareholder return. This suggests interest has been building around the...

If you are wondering whether Capgemini shares are starting to look interesting at current levels, this article will walk through what the current market price might be implying about the company’s value. The stock last closed at €134.30, with returns of a 1.5% decline over 7 days, a 4.6% decline over 30 days, a 4.6% decline year to date, a 21.2% decline over 1 year and a 23.1% decline over 3 years, while the 5 year return sits at 11.4%. Recent coverage has focused on how global IT services...

Recently, Barclays initiated coverage on Inventiva with an Overweight rating, while H.C. Wainwright reiterated its positive stance following a Keystone Obesity Conference presentation on a next-generation conjugate linked to lead candidate lanifibranor and the company’s announcement of a US$172.5 million equity financing to support its NATiV3 Phase 3 trial. Together, the supportive analyst views, external scientific validation, and fresh funding illustrate how Inventiva is working to advance...

Publicis Groupe recently reported financial results showing organic revenue growth of 5.7% and reaffirmed its full-year guidance of 5.5%, despite ongoing industry challenges. The company emphasized that client demand has held firm, suggesting its integrated communications and marketing model is withstanding sector pressures better than some peers. We’ll now examine how resilient client demand and reaffirmed guidance shape Publicis Groupe’s investment narrative over the coming period. We've...

STMicroelectronics reported full-year 2025 revenue of US$11.80 billion and net income of US$166 million, sharply lower than the prior year, while Q4 revenue of US$3.33 billion and a 35.2% gross margin came in above the company’s outlook midpoints. Alongside completing a US$440 million share buyback program, management issued softer Q1 2026 revenue guidance but voiced confidence in organic growth for 2026 across Automotive, Industrial, Personal Electronics, and data-center markets. We’ll now...

Alten S.A. held its Q4 2025 sales and trading statement call on 29 January 2026, updating investors on recent business activity and performance. The call gave the market fresh insight into how management views the company’s operational momentum and priorities heading into 2026. We’ll now examine how the latest Q4 2025 sales update, alongside the recent share price performance, shapes Alten’s investment narrative. Uncover the next big thing with financially sound penny stocks that balance...

CEO shake up and what it might mean for ERAMET ERAMET (ENXTPA:ERA) has moved quickly to terminate Chief Executive Officer Paulo Castellari due to differences in operating methods, appointing Chairwoman Christel Bories as interim CEO while a permanent successor is identified. For you as an investor, this kind of abrupt leadership change can raise questions about how aligned the Board and former management were on execution, capital allocation and operational priorities across manganese, nickel...

Event context and recent share performance Compagnie de Saint-Gobain (ENXTPA:SGO) has been on investors’ radar after recent share moves, with the stock showing a 4.4% decline over the past month and a 1.9% gain over the past 3 months. See our latest analysis for Compagnie de Saint-Gobain. Set against a €83.22 share price, the recent 1 month share price return of a 4.4% decline and 1 year total shareholder return of a 2.15% decline suggest fading momentum after strong 3 and 5 year total...

As the eurozone continues its modest recovery, with consumer and business confidence on the rise, investors are exploring opportunities in various segments of the market. Penny stocks, though often associated with speculative ventures, can still offer significant potential when grounded in strong financials. In this article, we will explore three European penny stocks that exemplify financial strength and growth potential in today's evolving market landscape.

In January 2026, Antin Infrastructure Partners announced a broad reshaping of its senior leadership, including appointing Stéphane Ifker and Angelika Schöchlin as co-Chief Investment Officers, new co-heads for its New York office, a new head for its NextGen strategy, and expanded representation on its Investment Committee. This reorganization concentrates decision-making across Antin’s Flagship, Mid Cap and NextGen strategies, potentially changing how the firm sources, executes and manages...